Zobrazeno 1 - 10 of 23 pro vyhledávání: '"Markus Perl"'
1
Akademický článek
From standard therapies to monoclonal antibodies and immune checkpoint inhibitors – an update for reconstructive surgeons on common oncological cases
Autor: Leonard Knoedler, Lioba Huelsboemer, Katharina Hollmann, Michael Alfertshofer, Konstantin Herfeld, Helia Hosseini, Sam Boroumand, Viola A. Stoegner, Ali-Farid Safi, Markus Perl, Samuel Knoedler, Bohdan Pomahac, Martin Kauke-Navarro
Publikováno v: Frontiers in Immunology, Vol 15 (2024)
Malignancies represent a persisting worldwide health burden. Tumor treatment is commonly based on surgical and/or non-surgical therapies. In the recent decade, novel non-surgical treatment strategies involving monoclonal antibodies (mAB) and immune c
Externí odkaz: https://doaj.org/article/7318d3bbb6eb4b1d84d3ea5542bc12af
Zobrazit plný text záznamu
2
Akademický článek
Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies
Autor: Markus Perl, Konstantin Herfeld, Dennis C. Harrer, Matthias Höpting, Marina Schweiger, Ulrich Sterz, Leonard Knödler, Susanne Heimerl, Leo Hansmann, Wolfgang Herr, Hendrik Poeck, Daniel Wolff, Matthias Edinger, Christina Hart, Matthias A. Fante
Publikováno v: Haematologica, Vol 999, Iss 1 (2024)
Chimeric antigen receptor (CAR-) T cell therapy causes serious side effects including cytokine release syndrome (CRS). CRS-related coagulopathy is associated with hypofibrinogenemia that is thus far considered the result of disseminated intravascular
Externí odkaz: https://doaj.org/article/e29209f4a56541ba8d1fab59aae25ed7
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje